Webinar

#Cell and gene therapy #Cell therapy #Gene therapy #Webinar

Upcoming advances and challenges in cell & gene therapies webinar

Hosted by Drug Discovery World and supported by Bio-Techne this webinar will explore the advances and challenges taking place within the cell and gene therapy field. You will hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo… Read More

#News

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Last chance to register: How AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Webinar: How AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News

#Biomarkers #Drug discovery #Evotec #Webinar

Webinar explores how modeling shapes clinical strategy

Clinical trials continue to experience high attrition rates, with lack of efficacy being one of the leading causes of failure. However, in many cases, these failures do not reflect a lack of drug efficacy, but rather limitations in translational biomarker strategies and selection of disease-relevant pharmacodynamic (PD) biomarkers, suboptimal dose… Read More

#News

#Biomarkers #Drug discovery #Evotec #Webinar

From PK/PD and Biomarkers to decision-making: How modeling shapes clinical strategy

Clinical trials continue to experience high attrition rates, with lack of efficacy being one of the leading causes of failure. However, in many cases, these failures do not reflect a lack of drug efficacy, but rather limitations in translational biomarker strategies and selection of disease-relevant pharmacodynamic (PD) biomarkers, suboptimal dose… Read More

Webinar date:
Supported by Evotec
#Featured Webinars #Webinars

#Cell and gene therapy #Cell therapy #Drug discovery #Webinar

Webinar: Advances and challenges in cell & gene therapies

Hosted by Drug Discovery World and supported by Bio-Techne this webinar will explore the advances and challenges taking place within the cell and gene therapy field. You will hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo… Read More

#News

Artificial intelligence
#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Webinar presents your infinite program team with AI

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News

#Cell and gene therapy #Cell therapy #Drug discovery #Gene therapy #Webinar

Have you registered for our CGT webinar?

Hosted by Drug Discovery World and supported by Bio-Techne this webinar will explore the advances and challenges taking place within the cell and gene therapy field. You will hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo… Read More

#News

#Cell and gene therapy #Drug development #Drug discovery #Webinar

Webinar – Advances in cell and gene therapy

Hosted by Drug Discovery World and supported by Bio-Techne this webinar will explore the advances and challenges taking place within the cell and gene therapy field. You will hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo… Read More

#News

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Webinar explores how AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News

Cell and gene therapy concept
#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

Register now: Cell and gene therapy webinar

Hosted by Drug Discovery World and supported by Bio-Techne this webinar will explore the advances and challenges taking place within the cell and gene therapy field. You will hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo… Read More

#News

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Americas Session – Your infinite program team: How AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, hosted by… Read More

Webinar date:
Supported by Benchling
#Webinars

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Europe Session – Your infinite program team: How AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, hosted by… Read More

Webinar date:
Supported by Benchling
#Webinars

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

New webinar – Your infinite program team: How AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News

#BioIVT #Cancer research #Drug development #Drug discovery #iOnctura #Kazia Therapeutics #Sartorius #Vyriad Therapeutics #Webinar

Last chance to register: Drug discovery challenges in cancer research

Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics… Read More

#News

Heavy-chain-only antibody
#3DEXPERIENCE cloud platform #Affinity maturation #Antibodies #BIOVIA #Deep learning #Webinar

Register now: Antibody affinity maturation through deep learning and mutation analysis

This webinar, hosted by DDW, explores how deep learning and physics-based methods can be combined to improve antibody affinity maturation and epitope mapping using workflows available in BIOVIA Discovery Studio Simulation on the 3DEXPERIENCE cloud platform. Through case studies involving antibody-antigen and nanobody-receptor complexes, the work demonstrates how virtual mutagenesis,… Read More

#News